Reverse Transcriptase News and Research

RSS
Ardea Biosciences completes phase 1 trials of HIV drug RDEA806

Ardea Biosciences completes phase 1 trials of HIV drug RDEA806

Tibotec Pharmaceuticals submits NDA for investigational HIV treatment

Tibotec Pharmaceuticals submits NDA for investigational HIV treatment

Etravirine reduces HIV viral loads when taken with Prezista

Etravirine reduces HIV viral loads when taken with Prezista

Etravirine effective for HIV supression

Etravirine effective for HIV supression

Entecavir can compromise HIV treatment

Entecavir can compromise HIV treatment

Drug warning prompts treatment changes for those infected with hepatitis B and HIV

Drug warning prompts treatment changes for those infected with hepatitis B and HIV

Major breakthrough for people with AIDS is on the horizon

Major breakthrough for people with AIDS is on the horizon

Flash-heating breast milk infected with HIV successfully deactivates virus

Flash-heating breast milk infected with HIV successfully deactivates virus

Drg resistant HIV quickly hides in infants' cells

Drg resistant HIV quickly hides in infants' cells

Decoy receptor 3 expressed in rheumatic synovial fibroblasts protects the cells against Fas-induced apoptosis

Decoy receptor 3 expressed in rheumatic synovial fibroblasts protects the cells against Fas-induced apoptosis

Two experimental drugs aimed at controlling viral loads among HIV-positive people who have developed drug resistance show promise

Two experimental drugs aimed at controlling viral loads among HIV-positive people who have developed drug resistance show promise

Bristol-Myers Squibb and Medivira announce collaboration to commercialize HIV treatment

Bristol-Myers Squibb and Medivira announce collaboration to commercialize HIV treatment

Researchers find way to decrease risk of atherosclerosis that accompanies long-term use of protease inhibitors

Researchers find way to decrease risk of atherosclerosis that accompanies long-term use of protease inhibitors

FDA approves Atripla for the treatment of HIV-1 infection in adults

FDA approves Atripla for the treatment of HIV-1 infection in adults

FDA gives tentative approval for generic pediatric AIDS drug

FDA gives tentative approval for generic pediatric AIDS drug

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir)

FDA gives tentative approval to new generic AIDS drug

FDA gives tentative approval to new generic AIDS drug

An engineered virus that tracks down and compels cancer cells to eat themselves

An engineered virus that tracks down and compels cancer cells to eat themselves

Cells have a natural defense against HIV

Cells have a natural defense against HIV

Completely novel approach to fighting HIV infections

Completely novel approach to fighting HIV infections